Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v70,p408)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trojano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trojano, M.
Related Collections
Right arrow Multiple sclerosis
Right arrowRelated Article
Neurology, Vol. 69, Issue 15, 1478-1479, October 9, 2007

EDITORIALS

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

Maria Trojano

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Related Article

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
M. G. Brown, S. Kirby, C. Skedgel, J. D. Fisk, T. J. Murray, V. Bhan, and I. S. Sketris
Neurology 2007 69: 1498-1507. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Mult SclerHome page
P. Veugelers, J. Fisk, M. Brown, K. Stadnyk, I. Sketris, T. Murray, and V. Bhan
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation
Multiple Sclerosis, November 1, 2009; 15(11): 1286 - 1294.
[Abstract] [PDF]

Home page
 NeurologyHome page
S. R. Brenner, M.G. Brown, S. Kirby, C. Skedgel, J.D. Fisk, T.J. Murray, V. Bhan, and I.S. Sketris
HOW EFFECTIVE ARE DISEASE-MODIFYING DRUGS IN DELAYING PROGRESSION IN RELAPSING-ONSET MS?
Neurology, August 19, 2008; 71(8): 615 - 616.
[Full Text] [PDF]

Home page
 NeurologyHome page
D. E. Wilkins and M. Trojano
IS IT TIME TO USE OBSERVATIONAL DATA TO ESTIMATE TREATMENT EFFECTIVENESS IN MULTIPLE SCLEROSIS?
Neurology, August 5, 2008; 71(6): 463 - 464.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?
Dennis E. Wilkins
Neurology Online, 24 Jan 2008 [Full text]
Reply from the author
Maria Trojano
Neurology Online, 24 Jan 2008 [Full text]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v70,p408)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trojano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trojano, M.
Related Collections
Right arrow Multiple sclerosis
Right arrowRelated Article